GAO Yan-bin’s experience in treating adult Immunoglobulin A vasculitis-associated nephritis from collateral disease.GAO Yan-bin’s experience in treating adult Immunoglobulin A vasculitis-associated nephritis from collateral disease[J]. Beijing Journal of Traditional Chinese Medicine,2022,41(07):746-750.
GAO Yan-bin’s experience in treating adult Immunoglobulin A vasculitis-associated nephritis from collateral disease.GAO Yan-bin’s experience in treating adult Immunoglobulin A vasculitis-associated nephritis from collateral disease[J]. Beijing Journal of Traditional Chinese Medicine,2022,41(07):746-750. DOI: 10.16025/j.1674-1307.2022.07.010.
GAO Yan-bin’s experience in treating adult Immunoglobulin A vasculitis-associated nephritis from collateral disease
DEMIR S,KAPLAN O,CELEBIER M,et al.Predictive biomarkers of IgA vasculitis with nephritis by metabolomic analysis[J].Semin Arthritis Rheum,2020,50(6):1238-1244.
PIRAM M,MAHR A.Epidemiology of immunoglobulin A vasculitis(Henoch-Schonlein):current state of knowledge[J].Curr Opin Rheumatol,2013,25(2):171-178.
NARCHI H.Risk of long term renal impairment and duration of follow up recommended for Henoch-Schonlein purpura with normal or minimal urinary findings:a systematic review[J].Arch Dis Child,2005,90(9):916-920.
SELEWSKI DT,AMBRUZS JM,APPEL GB,et al.Clinical characteristics and treatment patterns of children and adults with IgA nephropathy or IgA vasculitis:findings from the cure GN study[J].Kidney Int Rep,2018,3(6):1373-1384.
HAHN D,HODSON EM,WILLIS NS,et al.Interventions for preventing and treating kidney disease in Henoch-Schönlein Purpura(HSP)[J].Cochrane Database Syst Rev,2015,7(8):CD005128.
PILLEBOUT E,ALBERTI C,GUILLEVIN L,et al.Addition of cyclophosphamide to steroids provides no benefit compared with steroids alone in treating adult patients with severe Henoch Schönlein Purpura[J].Kidney Int,2010,78(5):495-502.
HOU JH,LE WB,CHEN N,et al.Mycophenolate mofetil combined with prednisone versus full-dose prednisone in IgA nephropathy with active proliferative lesions: a randomized controlled trial[J].Am J Kidney Dis,2017,69(6):788-795.
RAUEN T,WIED S,FITZNER C,et al.After ten years of follow-up,no difference between supportive care plus immunosuppression and supportive care alone in IgA nephropathy[J].Kidney Int,2020,98(4):1044-1052.
HALLING SF,SÖDERBERG MP,BERG UB.Henoch Schönlein nephritis:clinical findings related to renal function and morphology[J].Pediatr Nephrol,2005,20(1):46-51.
JENNETTE JC,FALK RJ,BACON PA,et al.2012 revised International Chapel Hill consensus conference nomenclature of vasculitides[J].Arthritis Rheum,2013,65(1):1-11.
POTERUCHA TJ,WETTER DA,GIBSON LE,et al.Histopathology and correlates of systemic disease in adult Henoch-Schönlein purpura:a retrospective study of microscopic and clinical findings in 68 patients at Mayo Clinic[J].J Am Acad Dermatol,2013,68(3):420-424.
Review of research on treating diabetic peripheral neuropathy from collateral disease theory
BAI Yan-ping’s experience in treating skin diseases by differentiation of meridians and collaterals
Expert advice of TCM experts on prevention and treatment of influenza in winter from 2021 to 2022
Progress in diagnosis and treatment of coronary heart disease with integrated traditional Chinese and western medicine
JIA Li-qun's experience in making differentiation and treatment of female triad by applying the theory of stagnation of liver and spleen being the causes